JOHN RICHARD: Open Payments
NPI 1124047717 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$53,903 in 362 payments from 44 companies in 2025. Trend: 2023 $20,672 · 2024 $35,277 · 2025 $53,903
Debt forgiveness: $33,600Speaker / faculty: $11,720Food & beverage: $6,891Travel & lodging: $1,532Education: $160
| Company | Payments | Amount |
|---|---|---|
| ConvaTec Inc. | 7 | $33,600 |
| Amgen Inc. | 46 | $9,845 |
| Paratek Pharmaceuticals, Inc. | 21 | $4,464 |
| Otsuka America Pharmaceutical, Inc. | 35 | $642 |
| Vanda Pharmaceuticals Inc. | 24 | $561 |
| Novo Nordisk Inc | 24 | $531 |
| Axsome Therapeutics, Inc. | 18 | $445 |
| ABBVIE INC. | 40 | $442 |
| Janssen Biotech, Inc. | 11 | $371 |
| Phathom Pharmaceuticals, Inc. | 23 | $358 |
Products named: INNOVAMATRIX AC, REPATHA, NUZYRA, REXULTI, FANAPT, Ozempic, TREMFYA, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
